BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Patient Worthy - ECPv5.12.4//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Patient Worthy
X-ORIGINAL-URL:https://patientworthy.com
X-WR-CALDESC:Events for Patient Worthy
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T123000
DTEND;TZID=America/New_York:20200924T133000
DTSTAMP:20260523T234229
CREATED:20200911T200143Z
LAST-MODIFIED:20200911T200143Z
UID:281011-1600950600-1600954200@patientworthy.com
SUMMARY:CureDuchenne Webinar: Italfarmaco Givinostat Program Update
DESCRIPTION:CureDuchenne Webinar: Update on the Italfarmaco Givinostat Program\nSeptember 24\, 2020 \nHear from Dr. Paolo Bettica about the latest news related to Italfarmaco’s investigational therapy givinostat\, which is being tested as a possible treatment for Duchenne muscular dystrophy\, Becker muscular dystrophy\, and a variety of other serious diseases. \nDon’t miss this special chance to hear the latest updates and ask questions about the progress of the development program. \nClick here to register for this event.
URL:https://patientworthy.com/event/cureduchenne-webinar-italfarmaco-givinostat-program-update/
CATEGORIES:Duchenne Muscular Dystrophy
ORGANIZER;CN="CureDuchenne":MAILTO:info@cureduchenne.org
END:VEVENT
END:VCALENDAR